LU79884A1 - - Google Patents

Info

Publication number
LU79884A1
LU79884A1 LU79884A LU79884A LU79884A1 LU 79884 A1 LU79884 A1 LU 79884A1 LU 79884 A LU79884 A LU 79884A LU 79884 A LU79884 A LU 79884A LU 79884 A1 LU79884 A1 LU 79884A1
Authority
LU
Luxembourg
Application number
LU79884A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU79884A1 publication Critical patent/LU79884A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015—Esters of acyclic unsaturated acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
LU79884A 1977-06-30 1978-06-28 LU79884A1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772729960 DE2729960A1 (de) 1977-06-30 1977-06-30 Neue acetylenprostaglandine und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
LU79884A1 true LU79884A1 (xx) 1978-12-07

Family

ID=6013006

Family Applications (1)

Application Number Title Priority Date Filing Date
LU79884A LU79884A1 (xx) 1977-06-30 1978-06-28

Country Status (11)

Country Link
US (1) US4235930A (xx)
JP (1) JPS5412352A (xx)
BE (1) BE868637A (xx)
CH (1) CH636082A5 (xx)
DE (1) DE2729960A1 (xx)
FR (1) FR2395993A1 (xx)
GB (1) GB2002348B (xx)
IE (1) IE47549B1 (xx)
IT (1) IT1108968B (xx)
LU (1) LU79884A1 (xx)
NL (1) NL7807168A (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3041602A1 (de) * 1980-10-31 1982-06-16 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue 5-cyan-prostacyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4552898A (en) * 1982-07-14 1985-11-12 Syntex (U.S.A.) Inc. [3.2.0]Bicycloheptanone oxime ethers with valuable therapeutic properties
DE3708537A1 (de) * 1987-03-13 1988-09-22 Schering Ag 6-oxoprostaglandin-e-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
US5545665A (en) 1993-12-28 1996-08-13 Allergan Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
WO2014015247A1 (en) 2012-07-19 2014-01-23 Cayman Chemical Company, Inc. Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions
DK3456710T3 (da) * 2016-05-09 2021-09-13 Agc Inc Nyt prostaglandinderivat
CN107365329B (zh) * 2016-05-12 2019-02-01 华东师范大学 一种3-甲基-2-氧代-5-庚炔基磷酸二甲酯的制备方法
CN107324986B (zh) * 2017-01-06 2021-04-30 常州博海威医药科技股份有限公司 16(s)-伊洛前列腺素的制备方法及应用
EP3705472B1 (en) * 2017-10-31 2023-06-21 AGC Inc. Method for producing prostaglandin derivative
JP6705974B2 (ja) * 2017-11-08 2020-06-03 Ａｇｃ株式会社 新規なプロスタグランジン誘導体を有効成分として含有する医薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA711840B (en) * 1970-04-20 1972-01-26 Upjohn Co Pge3-type compounds
DE2517771A1 (de) * 1975-04-18 1976-10-28 Schering Ag Neue prostaglandin-acetylen-analoga und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
IE781323L (en) 1978-12-30
GB2002348A (en) 1979-02-21
GB2002348B (en) 1982-03-31
IE47549B1 (en) 1984-04-18
DE2729960A1 (de) 1979-01-18
CH636082A5 (de) 1983-05-13
BE868637A (fr) 1979-01-02
FR2395993A1 (fr) 1979-01-26
NL7807168A (nl) 1979-01-03
JPS5412352A (en) 1979-01-30
US4235930A (en) 1980-11-25
IT1108968B (it) 1985-12-16
IT7825106A0 (it) 1978-06-29
FR2395993B1 (xx) 1980-10-31

Similar Documents

Publication Publication Date Title
FR2378858B1 (xx)
FR2378930B1 (xx)
FR2377190B1 (xx)
FR2379085B1 (xx)
FR2378594B2 (xx)
AU495917B2 (xx)
AR210643A1 (xx)
AU71461S (xx)
BG25822A1 (xx)
BG25855A1 (xx)
BG25811A1 (xx)
BG25812A1 (xx)
BG24331A1 (xx)
BG23462A1 (xx)
BG23438A1 (xx)
BG25813A1 (xx)
BE873002A (xx)
BE851449A (xx)
BE865722A (xx)
BG25815A1 (xx)
BG25819A1 (xx)
BG25820A1 (xx)
BE866391A (xx)
BE868323A (xx)
BG24713A1 (xx)